Compare American Water Works Company Inc (AWK) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Water Works Company Inc vs ResMed Inc. — how do they compare? American Water Works Company Inc trades at $131.69 (market cap $25.69B), while ResMed Inc. trades at $193.41 (market cap $28.79B). The key difference: American Water Works Company Inc and ResMed Inc. are close in size by market cap, and American Water Works Company Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| AWK | RMD | |
|---|---|---|
Market Cap | $25.69B | $28.79B |
Sector | Utilities | Health |
52-Week High | $147.00 | $293.73 |
52-Week Low | $121.13 | $182.82 |
Enterprise Value | $41.25B | $27.98B |
Dividend Yield | 2.72% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Water Works Company Inc
American Water Works is the largest investor-owned U.S. water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's only nonregulated business is water services for military bases, which operates under long-term contracts.
Read more on AWK →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
